Literature DB >> 6479099

Low levels of intestinal vitamin D-dependent calcium-binding protein in juvenile X-linked hypophosphatemic mice.

M E Bruns, R A Meyer, M H Meyer.   

Abstract

Hyp mice are a model for human X-linked hypophosphatemia, the most common form of vitamin D-resistant rickets. The developmental appearance of intestinal vitamin D-dependent calcium-binding protein (CaBP) and alkaline phosphatase was studied in Hyp mice and normal mice from the perinatal period to adulthood. Both intestinal proteins were increased in the duodenum during weeks 2 and 3 of age, with values rising 10-fold or more above values measured in intestines of 1-week-old mice. During this developmental period and at most other ages, Hyp mice had levels of alkaline phosphatase and total intestinal protein comparable to those in control mice. On the other hand, the concentration of intestinal CaBP was decreased in juvenile Hyp mice during the weaning period at 2-3 weeks of age (35-65% of normal) and further depressed in the rapid growth phase at 4-6 weeks of age (15-45% of normal). During adulthood (7-35 weeks of age) Hyp mice maintained a CaBP concentration that averaged 71% of the level of control mice. These maturational defects in the Hyp intestine may play a contributory role in the bone disease in young Hyp mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6479099     DOI: 10.1210/endo-115-4-1459

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Response of jejunal phosphate absorption to 1,25-dihydroxyvitamin D(3) stimulationin vivo in young X-linked hypophosphatemic (Hyp) mice.

Authors:  R A Meyer; M H Meyer; R W Gray; B A Brault
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

2.  Reduced absorption of 45calcium from isolated duodenal segments in vivo in juvenile but not adult X-linked hypophosphatemic mice.

Authors:  R A Meyer; M H Meyer; P R Erickson; A B Korkor
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.